Resilience in patients with lymphoid malignancies: The REPLY study

IF 0.5 4区医学 Q4 PSYCHIATRY

Annales medico-psychologiques Pub Date : 2025-02-01 DOI:10.1016/j.amp.2024.02.002

Gimena dos Santos, Vanesa Bogliacino, Victoria Irigoín, Cecilia Guillermo

{"title":"Resilience in patients with lymphoid malignancies: The REPLY study","authors":"Gimena dos Santos, Vanesa Bogliacino, Victoria Irigoín, Cecilia Guillermo","doi":"10.1016/j.amp.2024.02.002","DOIUrl":null,"url":null,"abstract":"<div><div>The role of resilience in lymphoid malignancies is not fully elucidated. The aims of this cross-sectional study were to investigate resilience and to explore its relationships with quality of life and mental health outcomes in patients with lymphoid malignancies, in a University Hospital in Uruguay. RS-14 Resilience Scale, Hospital Anxiety and Depression Scale (HADS) and EQ-5D-5L scale were used. Results: 106 patients were enrolled: 77 non-Hodgkin lymphoma, 16 Hodgkin lymphoma and 13 chronic lymphocytic leukemias. The median RS-14 score was 85.5 (95% CI: 82.4–88.2), corresponding to a ‘moderately high’ level of resilience. Resilience negatively correlated with anxiety (<em>r</em>  <0.01) and depression (<em>r</em>  <0.01), and positively correlated with quality of life as assessed by the EQ-VAS (<em>r</em>  <0.001) and EQ-index (<em>r</em>  <0.001). When further exploring the dimensions within the EQ-5D system we found that high resilience patients reported significantly less problems than moderate and low resilience patients. Moreover, among patients who did not report problems in any of the dimensions (i.e.: EQ-index=1), 66.7% were high resilients, 26.7% moderate and 6.7% were low resilients, further highlighting the importance of resilience in the ability to cope with the disease. In conclusion, resilience could be a protective factor for patients with lymphoid malignancies. Stimulating resilience through specific interventions could positively impact their quality of life.</div></div>","PeriodicalId":7992,"journal":{"name":"Annales medico-psychologiques","volume":"183 2","pages":"Pages 129-135"},"PeriodicalIF":0.5000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales medico-psychologiques","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0003448724000519","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

The role of resilience in lymphoid malignancies is not fully elucidated. The aims of this cross-sectional study were to investigate resilience and to explore its relationships with quality of life and mental health outcomes in patients with lymphoid malignancies, in a University Hospital in Uruguay. RS-14 Resilience Scale, Hospital Anxiety and Depression Scale (HADS) and EQ-5D-5L scale were used. Results: 106 patients were enrolled: 77 non-Hodgkin lymphoma, 16 Hodgkin lymphoma and 13 chronic lymphocytic leukemias. The median RS-14 score was 85.5 (95% CI: 82.4–88.2), corresponding to a ‘moderately high’ level of resilience. Resilience negatively correlated with anxiety (r = –0.487, P < 0.01) and depression (r = –0.607, P < 0.01), and positively correlated with quality of life as assessed by the EQ-VAS (r = 0.507, P < 0.001) and EQ-index (r = 0.345, P < 0.001). When further exploring the dimensions within the EQ-5D system we found that high resilience patients reported significantly less problems than moderate and low resilience patients. Moreover, among patients who did not report problems in any of the dimensions (i.e.: EQ-index = 1), 66.7% were high resilients, 26.7% moderate and 6.7% were low resilients, further highlighting the importance of resilience in the ability to cope with the disease. In conclusion, resilience could be a protective factor for patients with lymphoid malignancies. Stimulating resilience through specific interventions could positively impact their quality of life.

查看原文本刊更多论文

淋巴细胞恶性肿瘤患者的恢复力：应答研究

弹性在淋巴细胞恶性肿瘤中的作用尚未完全阐明。本横断面研究的目的是调查恢复力，并探讨其与生活质量和心理健康结果在乌拉圭的一所大学医院淋巴细胞恶性肿瘤患者的关系。采用RS-14弹性量表、医院焦虑抑郁量表（HADS）和EQ-5D-5L量表。结果：106例患者入组：非霍奇金淋巴瘤77例，霍奇金淋巴瘤16例，慢性淋巴细胞白血病13例。RS-14评分中位数为85.5 (95% CI: 82.4-88.2)，对应于“中等高”的恢复能力水平。心理弹性与焦虑呈负相关(r = -0.487, P <；0.01)和抑郁(r = -0.607, P <；0.01)，且与EQ-VAS评估的生活质量呈正相关(r = 0.507, P <；0.001)和eq指数(r = 0.345, P <；0.001)。当进一步探索EQ-5D系统的维度时，我们发现高弹性患者报告的问题明显少于中等和低弹性患者。此外，在没有报告任何维度问题的患者中（即：eq指数= 1），66.7%为高弹性，26.7%为中等弹性，6.7%为低弹性，进一步突出了弹性在应对疾病能力中的重要性。总之，韧性可能是淋巴细胞恶性肿瘤患者的一个保护因素。通过具体的干预措施刺激恢复力可以对他们的生活质量产生积极影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annales medico-psychologiques 医学-精神病学

CiteScore

1.30

自引率

33.30%

发文量

196

审稿时长

4-8 weeks

期刊介绍： The Annales Médico-Psychologiques is a peer-reviewed medical journal covering the field of psychiatry. Articles are published in French or in English. The journal was established in 1843 and is published by Elsevier on behalf of the Société Médico-Psychologique. The journal publishes 10 times a year original articles covering biological, genetic, psychological, forensic and cultural issues relevant to the diagnosis and treatment of mental illness, as well as peer reviewed articles that have been presented and discussed during meetings of the Société Médico-Psychologique.To report on the major currents of thought of contemporary psychiatry, and to publish clinical and biological research of international standard, these are the aims of the Annales Médico-Psychologiques.